Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

SHE:300878 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	263.08	253.96	330.16	162.74	280.8	595.23
Trading Asset Securities	10	-	245.56	-	-	-
Cash & Short-Term Investments	273.08	253.96	575.73	162.74	280.8	595.23
Cash Growth	-15.79%	-55.89%	253.77%	-42.04%	-52.83%	269.97%
Accounts Receivable	132.42	165.71	264.97	333.89	409.9	299.68
Other Receivables	14.92	52.15	29.1	366.31	2.76	2.85
Receivables	147.34	217.87	294.07	700.2	412.65	302.52
Inventory	83.56	118.32	153.78	116.78	129.49	82.31
Other Current Assets	29.04	26.33	28.16	54.27	47.15	18.56
Total Current Assets	533.01	616.48	1,052	1,034	870.09	998.62
Property, Plant & Equipment	819.76	853.66	857.39	761.5	706.09	548.95
Long-Term Investments	25	25	26.55	25	19.96	19.96
Goodwill	10.89	10.97	27.08	27.22	17.62	-
Other Intangible Assets	32.26	33.59	35.67	37.56	39.31	30.07
Long-Term Deferred Tax Assets	43.56	54.67	27.07	16.63	24.59	6.12
Long-Term Deferred Charges	3.49	2.51	5.07	6.11	7.03	8.73
Other Long-Term Assets	20.02	55.44	31.17	6.52	8.62	16.34
Total Assets	1,488	1,652	2,062	1,915	1,693	1,629
Accounts Payable	65.69	78.85	101.12	95.75	97.26	115.67
Accrued Expenses	5.58	44.74	52.09	24.61	53.2	63.74
Short-Term Debt	-	10.01	261.9	257.25	50.06	14.71
Current Portion of Long-Term Debt	90.78	88.21	-	-	-	-
Current Portion of Leases	-	2.55	10.21	11.76	12.29	-
Current Income Taxes Payable	17.51	0.14	0.26	2.33	6.09	12.4
Current Unearned Revenue	20.89	11.18	14.7	15.79	8.39	4.35
Other Current Liabilities	27.55	4.7	5.28	5.58	5.12	2.77
Total Current Liabilities	228.01	240.38	445.55	413.07	232.4	213.65
Long-Term Debt	182.12	186.62	149.95	33.39	-	-
Long-Term Leases	3.08	5.18	13.18	16.71	19.99	-
Long-Term Unearned Revenue	37.84	38.92	42.83	32.65	25.01	26.08
Long-Term Deferred Tax Liabilities	7.32	7.4	2.03	7.67	6.89	4.66
Total Liabilities	458.37	478.5	653.55	503.49	284.28	244.39
Common Stock	144.79	144.79	144.79	144.79	80.44	80.44
Additional Paid-In Capital	680.77	680.77	680.77	680.77	745.12	745.12
Retained Earnings	238.37	382.11	565.05	572.29	571.76	555.7
Treasury Stock	-50	-50	-	-	-	-
Total Common Equity	1,014	1,158	1,391	1,398	1,397	1,381
Minority Interest	15.71	16.16	17.6	13.2	11.71	3.13
Shareholders' Equity	1,030	1,174	1,408	1,411	1,409	1,384
Total Liabilities & Equity	1,488	1,652	2,062	1,915	1,693	1,629
Total Debt	275.97	292.57	435.24	319.1	82.34	14.71
Net Cash (Debt)	-2.89	-38.61	140.48	-156.36	198.46	580.51
Net Cash Growth	-	-	-	-	-65.81%	-
Net Cash Per Share	-0.02	-0.27	0.94	-1.09	1.38	4.82
Filing Date Shares Outstanding	142.05	142.05	144.79	144.79	144.79	144.79
Total Common Shares Outstanding	142.05	142.05	144.79	144.79	144.79	144.79
Working Capital	305.01	376.1	606.19	620.93	637.69	784.97
Book Value Per Share	7.14	8.15	9.60	9.65	9.65	9.54
Tangible Book Value	970.77	1,113	1,328	1,333	1,340	1,351
Tangible Book Value Per Share	6.83	7.84	9.17	9.21	9.26	9.33
Buildings	-	728.27	408.8	344.26	239.09	106.98
Machinery	-	264.87	307.22	286.89	162.96	89.79
Construction In Progress	-	55.1	270.43	225.09	366.57	422.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.